dijous, 31 de juliol del 2014

Vittamed wins 2 CE Marks for non-invasive neuro-diagnostics




Boston-based Vittamed wins CE Mark approval for devices to monitor intracranial pressure and cerebral perfusion.





Vittamed wins 2 CE Marks for neurodiagnostic devices

Medtech maker Vittamed won CE Mark approval for a pair of ultrasound-based systems for monitoring intracranial pressure and cerebral perfusion, the company announced.


European regulators approved Vittamed's 205 intracranial pressure measurement and the 505 cerebrovascular autoregulation monitor, both of which use non-invasive headsets to monitor activity in the brain.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uKHkWL

Cap comentari:

Publica un comentari a l'entrada